Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(25%)

Results Posted

100%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_4

25%

Ph phase_3

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

3(75.0%)

Phase 4Post-market surveillance

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(2)

Detailed Status

Terminated1

Completed1

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 33 (75.0%)

Phase 41 (25.0%)

Trials by Status

terminated125%

completed125%

withdrawn125%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

withdrawnphase_3

Clinical Trials (4)

Showing 4 of 4 trials

NCT05694611Phase 3

Preterm Neonates Brain Ultrasound With CEUS and Elastography

Withdrawn

NCT05648812Phase 3

Neonatal Brain Ultrasound With CEUS and Elastography

Recruiting

NCT03235180Phase 4

Ultrasound Evaluation of Crohn's Disease

Terminated

NCT00000140Phase 3

The Silicone Study

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4